How do you go from what you were seeing locally to thinking about transfusion-related alpha-gal syndrome or TROGs?

Talk us through that.

I think the first thing is that one case I found really scary.

So basically the patient that I talked about from 2025, he got a standard of care product in the OR and it could have killed him.

We have very good anesthesiologists.

They responded appropriately.

I was very glad they reported it as a suspected transfusion reaction.

both in the US as you all set up your study, but then equally, it sounds like internationally.